Knoll Capital Management, LLC reported 31 positions worth $164.25M for the quarter ended Jun 30, 2026, down 3.0% on the prior quarter. It opened 1 new position, added to 4, trimmed 0 and exited 2. Its largest holding is MeiraGTx Holdings plc at 10.3% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| ABVX Abivax S.A. | +35.0K | $4.66M | 2.84% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | MGTX MeiraGTx Holdings plc | Healthcare | 1.25M | $16.89M | 10.28% | 0 | 0.0% | Unchanged | 1.33% |
| 2 | PHYS Sprott Physical Gold Trust | Others | 387.1K | $11.68M | 7.11% | 0 | 0.0% | Unchanged | 0.08% |
| 3 | ALDX Aldeyra Therapeutics, Inc. | Healthcare | 5.48M | $11.66M | 7.1% | 0 | 0.0% | Unchanged | 9.08% |
| 4 | OCUL Ocular Therapeutix, Inc | Healthcare | 1.15M | $11.30M | 6.88% | +550.0K | +91.6% | Added | 0.51% |
| 5 | RGLD Royal Gold Inc | Financial Services | 52.8K | $10.53M | 6.41% | 0 | 0.0% | Unchanged | 0.06% |
| 6 | NUVB Nuvation Bio Inc. | Healthcare | 1.60M | $9.08M | 5.53% | +100.0K | +6.7% | Added | 0.46% |
| 7 | AEM Agnico Eagle Mines Ltd | Basic Materials | 52.8K | $8.18M | 4.98% | 0 | 0.0% | Unchanged | 0.01% |
| 8 | SA Seabridge Gold Inc | Basic Materials | 317.0K | $8.16M | 4.97% | 0 | 0.0% | Unchanged | 0.31% |
| 9 | KGC Kinross Gold Corp | Basic Materials | 320.0K | $7.56M | 4.6% | 0 | 0.0% | Unchanged | 0.03% |
| 10 | OR OR Royalties Inc. | Financial Services | 225.0K | $7.12M | 4.33% | 0 | 0.0% | Unchanged | 0.12% |
| 11 | SSRM Ssr Mining Inc. | Basic Materials | 245.0K | $6.93M | 4.22% | 0 | 0.0% | Unchanged | 0.12% |
| 12 | FNV FRANCO NEVADA Corp | Financial Services | 32.0K | $6.67M | 4.06% | 0 | 0.0% | Unchanged | 0.02% |
| 13 | BAH Booz Allen Hamilton Holding Corp | Industrials | 13.0K | $5.69M | 3.47% | 0 | 0.0% | Unchanged | 0.01% |
| 14 | CGAU Centerra Gold Inc. | Basic Materials | 359.0K | $5.69M | 3.47% | 0 | 0.0% | Unchanged | 0.13% |
| 15 | ELTX Elicio Therapeutics, Inc. | Healthcare | 1.21M | $4.74M | 2.89% | +581.0K | +92.1% | Added | 5.53% |
Tip. Select a row to see that position’s full history at Knoll Capital Management.
As of its Q2 2026 13F filing, Knoll Capital Management, LLC’s five largest positions were MeiraGTx Holdings plc (MGTX) at 10.3%, Sprott Physical Gold Trust (PHYS) at 7.1%, Aldeyra Therapeutics, Inc. (ALDX) at 7.1%, Ocular Therapeutix, Inc (OCUL) at 6.9%, Royal Gold Inc (RGLD) at 6.4% of the reported portfolio.
Knoll Capital Management, LLC reported a 13F portfolio worth $164.25M across 31 positions for Q2 2026. That is down 3.0% from the previous quarter.
Its largest purchases by value were Ocular Therapeutix, Inc ($5.40M), Abivax S.A. ($4.66M), Elicio Therapeutics, Inc. ($2.27M). It opened 1 new positions.
Its largest sales by value were Biohaven Ltd. ($19.70M), Cardiol Therapeutics Inc. ($135.00K). It exited 2 positions entirely.
From the Form 13F-HR reports Knoll Capital Management, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.